image: It's a disease that has plagued humans since the Paleolithic era: tuberculosis. After centuries of deaths and decades of research, why are we still fighting this deadly disease? ACS Headline Science spoke with Clifton Barry, Ph.D., head of the tuberculosis unit at the National Institutes of Health about the challenges and breakthroughs in TB research. view more
Credit: The American Chemical Society
WASHINGTON, June 4, 2015 -- It's a disease that has plagued humans since the Paleolithic era: tuberculosis. After centuries of deaths and decades of research, why are we still fighting this deadly disease? ACS Headline Science spoke with Clifton Barry, Ph.D., head of the tuberculosis unit at the National Institutes of Health about the challenges and breakthroughs in TB research. Check out the interview in our latest episode: https://www.youtube.com/watch?v=HS-SWQllQgY.
###
Subscribe to the ACS channel at http://bit.ly/ACSYoutube and follow us on Twitter @ACSPressroom.
The American Chemical Society is a nonprofit organization chartered by the U.S. Congress. With more than 158,000 members, ACS is the world's largest scientific society and a global leader in providing access to chemistry-related research through its multiple databases, peer-reviewed journals and scientific conferences. Its main offices are in Washington, D.C., and Columbus, Ohio.
To automatically receive news releases from the American Chemical Society, contact newsroom@acs.org">newsroom@acs.org.